High-tech Assault on HIV: Gene Therapy

Paul Cotton
JAMA. 1994;272(16):1235-1236. doi:10.1001/jama.1994.03520160017007.
Text Size: A A A
Published online


GENE THERAPY may still be in its infancy, but it is cutting teeth on attempts to ameliorate human immunodeficiency virus (HIV) disease.

Indeed, knowledge about the HIV genome seems to have come faster than clinical advances in treating the infection itself, and work with HIV clearly is breaking new ground in the field of gene therapy in ways likely to have impact far beyond the treatment of AIDS.

The National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Md, is including several gene therapy approaches, along with other innovative cell transfer studies, in the new Strategic Program for Innovative Research on AIDS Treatment (SPIRAT). SPIRAT is "crucial," says NIAID Director Anthony Fauci, MD, because anti-HIV drugs "only partially and temporarily suppress" viral replication and are "hampered by toxicity and drug resistance."

Enthusiasm and Cooperation  There is "great enthusiasm about the potential of gene therapy" for treating HIV disease, says William


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.